Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

AC Immune S.A. (NQ: ACIU )

7.590 USD -0.070 (-0.91%)
Official Closing Price Updated: 7:58 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about AC Immune S.A.

< Previous 1 2 3 4 5 6 7 8 9 Next >
AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD™ 2021 Virtual Conference
From GlobeNewswire News Releases
AC Immune to Highlight Promising Alzheimer’s Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference
From GlobeNewswire News Releases
Why AC Immune Stock Surged Today
Researchers are excited about the potential of the biotech's investigational Alzheimer's vaccine. 
Tags Market News ACIU
From Motley Fool
50 Stocks Moving In Thursday's Mid-Day Session
Gainers RCM Technologies, Inc. (NASDAQ: RCMT) shares rose 85.60% to $6.85 in mid-day trading after the company reported its ... 
Tags BRN ACIU TGC
From Benzinga
Mid-Morning Market Update: RCM Technologies Shares Spike Higher, Even As Walt Disney Prepares to Announce Q1 Results
Following the market opening Thursday, the Dow traded up 0.13% to 31,479.23 while the NASDAQ rose 0.30% to 14,014.62. The S&P also rose, ... 
Tags MVIS News PULM
From Benzinga
ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Swiss biopharma AC Immune has released positive updates this week on both... 
Tags BIIB Market News Today's Market
From InvestorPlace
Alzheimer's Vaccine Prods AC Immune Stock To A Seven-Month High
Biotech company AC Immune said Thursday its Alzheimer's vaccine generated key antibodies in the brain, leading ACIU stock to pop. Shares hit a three-year high in premarket action. 
From Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers AC Immune (NASDAQ:ACIU) shares rose 113.26% to $15.59 during Thursday's pre-market session. The company's market cap stands ... 
Tags ANCN DMTK Pre/Market Outlook
From Benzinga
Thinking about buying stock in AC Immune, Sundial Growers, FSD Pharma, Intec Pharma, or Northern Dynasty Minerals?
InvestorsObserver issues critical PriceWatch Alerts for ACIU, SNDL, HUGE, NTEC, and NAK. 
From PR Newswire
AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally
AC Immune SA(NASDAQ:ACIU) soars in premarket on robust volume, on the heels ofpositive interim resultsfrom ... 
Tags Benzinga JNJ General
From Benzinga
AC Immune’s Alzheimer’s Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study
From GlobeNewswire News Releases
AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinson’s Disease
From GlobeNewswire News Releases
AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway
From GlobeNewswire News Releases
AC Immune (ACIU) Shares Cross Above 200 DMA
In trading on Monday, shares of AC Immune SA (ACIU) crossed above their 200 day moving average of $6.49, changing hands as high as $7.20 per share. AC Immune SA shares are currently trading up about... 
Tags Stocks
From Market News Video
AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay
From GlobeNewswire News Releases
Immunotherapy Pioneer Prof. Carl H. June Joins AC Immune’s Board of Directors
From GlobeNewswire News Releases
Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer
From GlobeNewswire News Releases
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SPRO FDA ETNB
From Benzinga
AC Immune: Q3 Earnings Insights
Shares of AC Immune (NASDAQ:ACIU) remained unaffected after the company reported Q3 results. Quarterly Results Earnings ... 
Tags Benzinga ACIU Earnings
From Benzinga
AC Immune Reports Q3 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
The Math Shows IBB Can Go To $170
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
AC Immune to Provide Strategy and Pipeline Update During Jefferies Virtual London Healthcare Conference
To feature discussion of the Company’s world-leading therapeutic and diagnostic candidates targeting TDP-43 
From GlobeNewswire News Releases
AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 Antibodies into Clinical Development
Strategic partnership reflects AC Immune’s growing expertise in monoclonal antibody development 
From GlobeNewswire News Releases
51 Biggest Movers From Yesterday
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 51.2% to close at $16.98 on Wednesday. Aptevo Therapeutics, on ... 
Tags News THMO KBLM
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Biogen Inc. (NASDAQ: BIIB) shares jumped 40.6% to $347.39 after FDA briefing documents showed company provided evidence of ... 
Tags News THMO Mid/Day Movers
From Benzinga
Relative Strength Alert For AC Immune
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer
From GlobeNewswire News Releases
Competitive EU Grant Supports Collaboration to Accelerate Development of AC Immune's First-in-Class TDP-43 Diagnostic Agent
From GlobeNewswire News Releases
IUSS's Underlying Holdings Could Mean 10% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Is Cassava Sciences Stock a Buy?
Can this emerging biotech with just nine employees solve a multibillion-dollar medical problem and enrich its investors? 
Tags BIIB Market News SAVA
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.